Government's bold initiatives: tackling cervical cancer in India with determination and commitment
Rabin Devnath,Kalicharan Sharma
DOI: https://doi.org/10.1080/03007995.2024.2388221
2024-08-18
Current Medical Research and Opinion
Abstract:Cervical cancer develops gradually due to aberrant cell proliferation and starts in the cervix, which is the vital pathway connecting the uterus and vagina. This global health risk is primarily caused by histological subtype of cervical cancer which are: squamous cell carcinoma, responsible for 90% of cases, and adenocarcinoma. The most common culprit is the human papillomavirus, HPV, which is frequently acquired through sexual contact. Although the majority of infections heal on their own, a few factors raise the possibility of HPV infection persisting and developing into cervical cancer. These include using birth control tablets regularly, obesity, smoking, and compromised immune systems Citation 1 . Cervical cancer is the fourth most frequent cancer worldwide among women, with 23% of cases occurring in India alone. Population-based cervical cancer screening is not yet widely used in the India because of conflicting healthcare goals, a lack of funding, and an inadequate number of qualified healthcare professionals. As a result, many instances appear at advanced stages, leading to higher death rates and worse survival rates. Cervical cancer can be detected early using a variety of screening tools, including cytology, visual-based methods, and testing for high-risk HPV Citation 2 . Globally cervical cancer accounts for around 604,000 cases annually. As the most common cancer among women, cervical cancer is highly widespread in India. With 365.71 million women over 15, thought to be at risk, the nation is responsible for around one-third of all cervical cancer fatalities globally Citation 3 . Based on this data, India leads Asia in the number of instances of cervical cancer, with China following closely behind. According to a Lancet study, cervical cancer caused 40% of all deaths; 23% of these deaths happened in India and 17% in China. Based on estimates from The Global Cancer Observatory (GLOBOCAN) 2020, the study takes temporal, socioeconomic, and geographic factors into account Citation 4 . Over 600,000 new instances of cervical cancer are expected worldwide in 2020, of which over 340,000 will result in fatalities. In densely populated nations including China, India, Indonesia, Russia, and Brazil, the incidence surpassed the 4 cases per 100,000 women, World Health Organisation (WHO) criterion. In particular, India recorded a startling 18 instances for per 100,000 females. According to the report, it will be difficult to reach the WHO eradication threshold by 2030 unless nations strengthen their screening initiatives and raise the rate of HPV vaccination Citation 5 . It is estimated that in a medium HDI country like India, efforts for scaling up HPV vaccination covering 80–100% of target population together with two cervical cancer screenings per lifetime would help achieve cervical cancer elimination by 2070–79 Citation 6 . Union Finance Minister Nirmala Sitharaman stated plans to concentrate on cervical cancer vaccination for girls aged 9 to 14 in the Interim Budget 2024 on 1st of February 2024, acknowledging the necessity of combating the disease. This pledge supports the fight against the illness and offers hope for more preventive actions. During her speech, the finance minister also revealed a number of additional health-related initiatives, such as expanding Ayushman Bharat coverage to include all Asha workers and Anganwadi workers and assistants Citation 7 . To prevent cervical cancer, the National Technical Advisory Group for Immunisation (NTAGI) of India proposed two years ago that the HPV vaccine be included in the Universal Immunisation Programme (UIP). Nevertheless, specifics regarding the government's plan are still unknown. While Sitharaman declared in her budget address that "our government will encourage vaccination for girls aged 9 to 14 years as a preventive measure against cervical cancer, there is no clear information in the plan of action. Cervical cancer is the second most frequent cancer among women worldwide, and it is largely due India. The Human Papillomavirus (HPV) is the main culprit, and because immunisation programmes are not widely available and awareness is low, the virus's prevalence is still significant. The prevalence of HPV and cervical cancer endures despite national cancer screening programmes being implemented by the central government. The Interna -Abstract Truncated-
medicine, general & internal, research & experimental